Affinity chromatography 2026-11-05
Affinity chromatography separates a target through its reversible, selective binding to a ligand immobilized on a chromatographic stationary phase. The chromatographic mobile phase carries a mixture through the material; components with little binding tend to pass through, while the target is retained. Washing removes unbound material, and changing suitable solution conditions or adding a competitor can release the target. Strong binding and recoverable binding are different design requirements.[ref]
For a concrete experimental comparison, prepare two otherwise similar columns: one bearing the intended ligand, the other lacking it. Load the same protein mixture, collect the flow-through, wash, and then collect the released material. Target enrichment specifically on the ligand-bearing material supports the intended binding mechanism. Retention on both columns instead suggests an additional interaction with the support; disappearance from the flow-through alone does not prove successful purification.
An original numerical example separates recovery from purity. Start with milligrams of target in milligrams of total protein. If the collected fraction contains milligrams of target in milligrams total, its target purity rises from to , while target recovery is . An activity assay may answer a further question: whether the recovered target remains functional.
In his 1970 report, Pedro Cuatrecasas described agarose derivatives for presenting binding partners on an insoluble support. The arrangement makes molecular recognition usable as a preparative tool: retain a chosen partner in one place, pass a complex mixture over it, and recover material selected by that interaction.[ref]
Meir Wilchek 2026-11-05
Meir Wilchek is a biochemist whose work helped establish affinity chromatography as a practical method of protein purification. His collaboration with Pedro Cuatrecasas used selective molecular recognition to retain a desired protein on a ligand-bearing support, connecting a biochemical interaction to a separation method.[ref]
The central idea differs from simply sorting proteins by size. An immobilized ligand supplies a binding partner for the target, while the experiment must still control unwanted retention and recover useful protein. The combination of specificity and reversibility makes a molecular interaction into an analytical tool.
For an illustrative comparison, two proteins of similar mass may behave differently on a column if only one recognizes the attached ligand. Conversely, a tightly retained protein is not automatically the intended target. Identity measurements and controls remain necessary. Wilchek's contribution is scientifically interesting because it makes biological selectivity useful for experimental isolation, rather than treating recognition only as a phenomenon to describe.[ref]
Figure 1.
Portrait of Meir Wilchek
. Photograph explicitly identified as Wilchek Meir in the official departmental directory.
Pedro Cuatrecasas 2026-11-05
Pedro Cuatrecasas was a biochemist who helped develop affinity chromatography and studied receptor biology. With collaborators including Meir Wilchek, he developed methods that used selective molecular binding to isolate particular proteins from complex mixtures.[ref]
His 1970 paper, Agarose Derivatives for Purification of Protein by Affinity Chromatography by Pedro Cuatrecasas, explained the organizing principle: attach a suitable ligand to an insoluble matrix, then exploit its reversible interaction with the desired macromolecule. The immobilized ligand supplies chemical selectivity, rather than requiring the target protein to be distinguished only by bulk size or charge.[ref]
The method separates capture from recovery. Binding a target is useful only if the experiment can distinguish it from other retained material and recover it in a usable state. This makes protein purification a problem of controlled interactions as well as apparatus. Cuatrecasas also applied binding measurements and affinity methods to the insulin receptor, connecting recognition of a hormone to a physically isolable molecular component.[ref]